nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Carmustine—melanoma	0.197	0.417	CbGbCtD
Rizatriptan—CYP1A2—Vemurafenib—melanoma	0.156	0.33	CbGbCtD
Rizatriptan—CYP1A2—Dacarbazine—melanoma	0.119	0.253	CbGbCtD
Rizatriptan—HTR1D—meninx—melanoma	0.0441	0.601	CbGeAlD
Rizatriptan—HTR1B—blood vessel—melanoma	0.00516	0.0704	CbGeAlD
Rizatriptan—HTR1D—blood vessel—melanoma	0.005	0.0682	CbGeAlD
Rizatriptan—HTR1F—head—melanoma	0.00381	0.0519	CbGeAlD
Rizatriptan—MAOA—neck—melanoma	0.00272	0.0372	CbGeAlD
Rizatriptan—HTR1D—eye—melanoma	0.00266	0.0363	CbGeAlD
Rizatriptan—MAOA—retina—melanoma	0.00201	0.0274	CbGeAlD
Rizatriptan—MAOA—mammalian vulva—melanoma	0.00161	0.0219	CbGeAlD
Rizatriptan—HTR1B—head—melanoma	0.00156	0.0213	CbGeAlD
Rizatriptan—HTR1D—head—melanoma	0.00151	0.0206	CbGeAlD
Rizatriptan—Melatonin—CYP1B1—melanoma	0.00151	0.71	CrCbGaD
Rizatriptan—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00136	0.00486	CcSEcCtD
Rizatriptan—Lacrimation increased—Docetaxel—melanoma	0.00136	0.00485	CcSEcCtD
Rizatriptan—Ataxia—Carmustine—melanoma	0.00133	0.00475	CcSEcCtD
Rizatriptan—Face oedema—Temozolomide—melanoma	0.00132	0.00471	CcSEcCtD
Rizatriptan—Hearing impaired—Docetaxel—melanoma	0.00132	0.0047	CcSEcCtD
Rizatriptan—Anaphylactic shock—Vemurafenib—melanoma	0.00132	0.00469	CcSEcCtD
Rizatriptan—Dysphagia—Dactinomycin—melanoma	0.00131	0.00466	CcSEcCtD
Rizatriptan—Nervous system disorder—Vemurafenib—melanoma	0.00129	0.0046	CcSEcCtD
Rizatriptan—Ataxia—Temozolomide—melanoma	0.00129	0.00459	CcSEcCtD
Rizatriptan—Dehydration—Temozolomide—melanoma	0.00127	0.00454	CcSEcCtD
Rizatriptan—HTR1A—head—melanoma	0.00126	0.0172	CbGeAlD
Rizatriptan—Blood pressure increased—Docetaxel—melanoma	0.00125	0.00447	CcSEcCtD
Rizatriptan—Muscular weakness—Carmustine—melanoma	0.00125	0.00445	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Bleomycin—melanoma	0.00123	0.00439	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00123	0.00439	CcSEcCtD
Rizatriptan—Myocardial infarction—Bleomycin—melanoma	0.00122	0.00437	CcSEcCtD
Rizatriptan—Dysphagia—Carmustine—melanoma	0.00122	0.00436	CcSEcCtD
Rizatriptan—Muscular weakness—Temozolomide—melanoma	0.00121	0.0043	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0012	0.00427	CcSEcCtD
Rizatriptan—Abdominal distension—Temozolomide—melanoma	0.00119	0.00425	CcSEcCtD
Rizatriptan—Dysphagia—Temozolomide—melanoma	0.00118	0.00422	CcSEcCtD
Rizatriptan—MAOA—head—melanoma	0.00115	0.0157	CbGeAlD
Rizatriptan—Decreased appetite—Vemurafenib—melanoma	0.00114	0.00408	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Vemurafenib—melanoma	0.00114	0.00405	CcSEcCtD
Rizatriptan—Fatigue—Vemurafenib—melanoma	0.00113	0.00405	CcSEcCtD
Rizatriptan—Constipation—Vemurafenib—melanoma	0.00112	0.00401	CcSEcCtD
Rizatriptan—Hypoaesthesia—Bleomycin—melanoma	0.00112	0.00398	CcSEcCtD
Rizatriptan—Dysuria—Temozolomide—melanoma	0.00111	0.00394	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Temozolomide—melanoma	0.0011	0.00392	CcSEcCtD
Rizatriptan—Pollakiuria—Temozolomide—melanoma	0.00109	0.0039	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Temozolomide—melanoma	0.00108	0.00385	CcSEcCtD
Rizatriptan—Flushing—Bleomycin—melanoma	0.00104	0.00371	CcSEcCtD
Rizatriptan—Body temperature increased—Vemurafenib—melanoma	0.00104	0.00371	CcSEcCtD
Rizatriptan—Pharyngitis—Dactinomycin—melanoma	0.00104	0.0037	CcSEcCtD
Rizatriptan—Swelling—Docetaxel—melanoma	0.00103	0.00368	CcSEcCtD
Rizatriptan—Deafness—Docetaxel—melanoma	0.00102	0.00363	CcSEcCtD
Rizatriptan—Chills—Bleomycin—melanoma	0.00101	0.00359	CcSEcCtD
Rizatriptan—Erythema—Bleomycin—melanoma	0.000976	0.00348	CcSEcCtD
Rizatriptan—Hallucination—Carmustine—melanoma	0.000974	0.00348	CcSEcCtD
Rizatriptan—Hypoaesthesia—Carmustine—melanoma	0.000974	0.00348	CcSEcCtD
Rizatriptan—Hot flush—Docetaxel—melanoma	0.000972	0.00347	CcSEcCtD
Rizatriptan—Flushing—Dactinomycin—melanoma	0.000971	0.00346	CcSEcCtD
Rizatriptan—Hypersensitivity—Vemurafenib—melanoma	0.000969	0.00346	CcSEcCtD
Rizatriptan—Menopausal symptoms—Docetaxel—melanoma	0.000964	0.00344	CcSEcCtD
Rizatriptan—Asthenia—Vemurafenib—melanoma	0.000943	0.00337	CcSEcCtD
Rizatriptan—Hallucination—Temozolomide—melanoma	0.000941	0.00336	CcSEcCtD
Rizatriptan—Hypoaesthesia—Temozolomide—melanoma	0.000941	0.00336	CcSEcCtD
Rizatriptan—Pharyngitis—Temozolomide—melanoma	0.000939	0.00335	CcSEcCtD
Rizatriptan—Chills—Dactinomycin—melanoma	0.000938	0.00335	CcSEcCtD
Rizatriptan—Pruritus—Vemurafenib—melanoma	0.00093	0.00332	CcSEcCtD
Rizatriptan—Erythema—Dactinomycin—melanoma	0.00091	0.00325	CcSEcCtD
Rizatriptan—Flushing—Carmustine—melanoma	0.000908	0.00324	CcSEcCtD
Rizatriptan—Diarrhoea—Vemurafenib—melanoma	0.0009	0.00321	CcSEcCtD
Rizatriptan—Tinnitus—Temozolomide—melanoma	0.000882	0.00315	CcSEcCtD
Rizatriptan—Flushing—Temozolomide—melanoma	0.000878	0.00313	CcSEcCtD
Rizatriptan—Arrhythmia—Carmustine—melanoma	0.000874	0.00312	CcSEcCtD
Rizatriptan—Dizziness—Vemurafenib—melanoma	0.00087	0.0031	CcSEcCtD
Rizatriptan—Angiopathy—Temozolomide—melanoma	0.000858	0.00306	CcSEcCtD
Rizatriptan—Mental disorder—Carmustine—melanoma	0.000858	0.00306	CcSEcCtD
Rizatriptan—Ataxia—Docetaxel—melanoma	0.000855	0.00305	CcSEcCtD
Rizatriptan—Erythema—Carmustine—melanoma	0.000852	0.00304	CcSEcCtD
Rizatriptan—Cough—Bleomycin—melanoma	0.000852	0.00304	CcSEcCtD
Rizatriptan—Chills—Temozolomide—melanoma	0.000849	0.00303	CcSEcCtD
Rizatriptan—Dehydration—Docetaxel—melanoma	0.000846	0.00302	CcSEcCtD
Rizatriptan—Vomiting—Vemurafenib—melanoma	0.000836	0.00298	CcSEcCtD
Rizatriptan—Chest pain—Bleomycin—melanoma	0.000831	0.00297	CcSEcCtD
Rizatriptan—Myalgia—Bleomycin—melanoma	0.000831	0.00297	CcSEcCtD
Rizatriptan—Rash—Vemurafenib—melanoma	0.000829	0.00296	CcSEcCtD
Rizatriptan—Mental disorder—Temozolomide—melanoma	0.000829	0.00296	CcSEcCtD
Rizatriptan—Dermatitis—Vemurafenib—melanoma	0.000828	0.00296	CcSEcCtD
Rizatriptan—Headache—Vemurafenib—melanoma	0.000824	0.00294	CcSEcCtD
Rizatriptan—Erythema—Temozolomide—melanoma	0.000823	0.00294	CcSEcCtD
Rizatriptan—Discomfort—Bleomycin—melanoma	0.000821	0.00293	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000819	0.00292	CcSEcCtD
Rizatriptan—Cramp muscle—Docetaxel—melanoma	0.000819	0.00292	CcSEcCtD
Rizatriptan—Nasopharyngitis—Docetaxel—melanoma	0.000813	0.0029	CcSEcCtD
Rizatriptan—Dysgeusia—Temozolomide—melanoma	0.000806	0.00288	CcSEcCtD
Rizatriptan—MAOA—lymph node—melanoma	0.000805	0.011	CbGeAlD
Rizatriptan—Confusional state—Bleomycin—melanoma	0.000803	0.00287	CcSEcCtD
Rizatriptan—Vision blurred—Carmustine—melanoma	0.000803	0.00287	CcSEcCtD
Rizatriptan—Tremor—Carmustine—melanoma	0.000798	0.00285	CcSEcCtD
Rizatriptan—Anaphylactic shock—Bleomycin—melanoma	0.000797	0.00284	CcSEcCtD
Rizatriptan—Oedema—Bleomycin—melanoma	0.000797	0.00284	CcSEcCtD
Rizatriptan—Dysphagia—Docetaxel—melanoma	0.000786	0.0028	CcSEcCtD
Rizatriptan—Agitation—Carmustine—melanoma	0.000783	0.00279	CcSEcCtD
Rizatriptan—Nausea—Vemurafenib—melanoma	0.000781	0.00279	CcSEcCtD
Rizatriptan—Vision blurred—Temozolomide—melanoma	0.000776	0.00277	CcSEcCtD
Rizatriptan—Myalgia—Dactinomycin—melanoma	0.000775	0.00277	CcSEcCtD
Rizatriptan—Tremor—Temozolomide—melanoma	0.000772	0.00275	CcSEcCtD
Rizatriptan—Discomfort—Dactinomycin—melanoma	0.000766	0.00273	CcSEcCtD
Rizatriptan—Angina pectoris—Docetaxel—melanoma	0.000766	0.00273	CcSEcCtD
Rizatriptan—Anorexia—Bleomycin—melanoma	0.000759	0.00271	CcSEcCtD
Rizatriptan—Agitation—Temozolomide—melanoma	0.000757	0.0027	CcSEcCtD
Rizatriptan—Angioedema—Temozolomide—melanoma	0.000752	0.00268	CcSEcCtD
Rizatriptan—Oedema—Dactinomycin—melanoma	0.000743	0.00265	CcSEcCtD
Rizatriptan—Vertigo—Temozolomide—melanoma	0.00074	0.00264	CcSEcCtD
Rizatriptan—Convulsion—Carmustine—melanoma	0.000738	0.00263	CcSEcCtD
Rizatriptan—Hypertension—Carmustine—melanoma	0.000736	0.00262	CcSEcCtD
Rizatriptan—Palpitations—Temozolomide—melanoma	0.000728	0.0026	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Bleomycin—melanoma	0.000726	0.00259	CcSEcCtD
Rizatriptan—Chest pain—Carmustine—melanoma	0.000725	0.00259	CcSEcCtD
Rizatriptan—Myalgia—Carmustine—melanoma	0.000725	0.00259	CcSEcCtD
Rizatriptan—Anxiety—Carmustine—melanoma	0.000723	0.00258	CcSEcCtD
Rizatriptan—Cough—Temozolomide—melanoma	0.000719	0.00256	CcSEcCtD
Rizatriptan—Paraesthesia—Bleomycin—melanoma	0.000715	0.00255	CcSEcCtD
Rizatriptan—Convulsion—Temozolomide—melanoma	0.000713	0.00255	CcSEcCtD
Rizatriptan—Hypertension—Temozolomide—melanoma	0.000711	0.00254	CcSEcCtD
Rizatriptan—Dyspnoea—Bleomycin—melanoma	0.00071	0.00253	CcSEcCtD
Rizatriptan—Anorexia—Dactinomycin—melanoma	0.000708	0.00253	CcSEcCtD
Rizatriptan—Confusional state—Carmustine—melanoma	0.000701	0.0025	CcSEcCtD
Rizatriptan—Arthralgia—Temozolomide—melanoma	0.000701	0.0025	CcSEcCtD
Rizatriptan—Myalgia—Temozolomide—melanoma	0.000701	0.0025	CcSEcCtD
Rizatriptan—Anxiety—Temozolomide—melanoma	0.000699	0.00249	CcSEcCtD
Rizatriptan—Oedema—Carmustine—melanoma	0.000695	0.00248	CcSEcCtD
Rizatriptan—Discomfort—Temozolomide—melanoma	0.000693	0.00247	CcSEcCtD
Rizatriptan—Decreased appetite—Bleomycin—melanoma	0.000693	0.00247	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Docetaxel—melanoma	0.000691	0.00246	CcSEcCtD
Rizatriptan—Myocardial infarction—Docetaxel—melanoma	0.000687	0.00245	CcSEcCtD
Rizatriptan—Dry mouth—Temozolomide—melanoma	0.000686	0.00245	CcSEcCtD
Rizatriptan—Pain—Bleomycin—melanoma	0.000681	0.00243	CcSEcCtD
Rizatriptan—Tachycardia—Carmustine—melanoma	0.000679	0.00242	CcSEcCtD
Rizatriptan—Confusional state—Temozolomide—melanoma	0.000678	0.00242	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000677	0.00242	CcSEcCtD
Rizatriptan—Oedema—Temozolomide—melanoma	0.000672	0.0024	CcSEcCtD
Rizatriptan—Anaphylactic shock—Temozolomide—melanoma	0.000672	0.0024	CcSEcCtD
Rizatriptan—Anorexia—Carmustine—melanoma	0.000663	0.00237	CcSEcCtD
Rizatriptan—Epistaxis—Docetaxel—melanoma	0.000661	0.00236	CcSEcCtD
Rizatriptan—Nervous system disorder—Temozolomide—melanoma	0.000659	0.00235	CcSEcCtD
Rizatriptan—Feeling abnormal—Bleomycin—melanoma	0.000657	0.00234	CcSEcCtD
Rizatriptan—Hyperhidrosis—Temozolomide—melanoma	0.00065	0.00232	CcSEcCtD
Rizatriptan—Decreased appetite—Dactinomycin—melanoma	0.000646	0.0023	CcSEcCtD
Rizatriptan—Fatigue—Dactinomycin—melanoma	0.000641	0.00229	CcSEcCtD
Rizatriptan—Anorexia—Temozolomide—melanoma	0.000641	0.00229	CcSEcCtD
Rizatriptan—Pain—Dactinomycin—melanoma	0.000635	0.00227	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Carmustine—melanoma	0.000634	0.00226	CcSEcCtD
Rizatriptan—Urticaria—Bleomycin—melanoma	0.000633	0.00226	CcSEcCtD
Rizatriptan—Body temperature increased—Bleomycin—melanoma	0.00063	0.00225	CcSEcCtD
Rizatriptan—Insomnia—Carmustine—melanoma	0.000629	0.00224	CcSEcCtD
Rizatriptan—Hypoaesthesia—Docetaxel—melanoma	0.000626	0.00223	CcSEcCtD
Rizatriptan—Paraesthesia—Carmustine—melanoma	0.000624	0.00223	CcSEcCtD
Rizatriptan—Pharyngitis—Docetaxel—melanoma	0.000624	0.00223	CcSEcCtD
Rizatriptan—Dyspnoea—Carmustine—melanoma	0.00062	0.00221	CcSEcCtD
Rizatriptan—Somnolence—Carmustine—melanoma	0.000618	0.00221	CcSEcCtD
Rizatriptan—Sumatriptan—ABCB1—melanoma	0.000617	0.29	CrCbGaD
Rizatriptan—Feeling abnormal—Dactinomycin—melanoma	0.000612	0.00218	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000612	0.00218	CcSEcCtD
Rizatriptan—Insomnia—Temozolomide—melanoma	0.000608	0.00217	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dactinomycin—melanoma	0.000608	0.00217	CcSEcCtD
Rizatriptan—Decreased appetite—Carmustine—melanoma	0.000605	0.00216	CcSEcCtD
Rizatriptan—Paraesthesia—Temozolomide—melanoma	0.000603	0.00215	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Carmustine—melanoma	0.0006	0.00214	CcSEcCtD
Rizatriptan—Dyspnoea—Temozolomide—melanoma	0.000599	0.00214	CcSEcCtD
Rizatriptan—Somnolence—Temozolomide—melanoma	0.000597	0.00213	CcSEcCtD
Rizatriptan—Pain—Carmustine—melanoma	0.000595	0.00212	CcSEcCtD
Rizatriptan—Constipation—Carmustine—melanoma	0.000595	0.00212	CcSEcCtD
Rizatriptan—Dyspepsia—Temozolomide—melanoma	0.000592	0.00211	CcSEcCtD
Rizatriptan—Abdominal pain—Dactinomycin—melanoma	0.000587	0.0021	CcSEcCtD
Rizatriptan—Body temperature increased—Dactinomycin—melanoma	0.000587	0.0021	CcSEcCtD
Rizatriptan—Hypersensitivity—Bleomycin—melanoma	0.000587	0.00209	CcSEcCtD
Rizatriptan—Decreased appetite—Temozolomide—melanoma	0.000584	0.00208	CcSEcCtD
Rizatriptan—Flushing—Docetaxel—melanoma	0.000584	0.00208	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Temozolomide—melanoma	0.00058	0.00207	CcSEcCtD
Rizatriptan—Fatigue—Temozolomide—melanoma	0.000579	0.00207	CcSEcCtD
Rizatriptan—Pain—Temozolomide—melanoma	0.000575	0.00205	CcSEcCtD
Rizatriptan—Constipation—Temozolomide—melanoma	0.000575	0.00205	CcSEcCtD
Rizatriptan—Feeling abnormal—Carmustine—melanoma	0.000573	0.00204	CcSEcCtD
Rizatriptan—Asthenia—Bleomycin—melanoma	0.000572	0.00204	CcSEcCtD
Rizatriptan—Angiopathy—Docetaxel—melanoma	0.000571	0.00204	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Carmustine—melanoma	0.000569	0.00203	CcSEcCtD
Rizatriptan—Chills—Docetaxel—melanoma	0.000564	0.00201	CcSEcCtD
Rizatriptan—Pruritus—Bleomycin—melanoma	0.000564	0.00201	CcSEcCtD
Rizatriptan—Arrhythmia—Docetaxel—melanoma	0.000562	0.00201	CcSEcCtD
Rizatriptan—Feeling abnormal—Temozolomide—melanoma	0.000554	0.00198	CcSEcCtD
Rizatriptan—Mental disorder—Docetaxel—melanoma	0.000551	0.00197	CcSEcCtD
Rizatriptan—Abdominal pain—Carmustine—melanoma	0.00055	0.00196	CcSEcCtD
Rizatriptan—Body temperature increased—Carmustine—melanoma	0.00055	0.00196	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Temozolomide—melanoma	0.00055	0.00196	CcSEcCtD
Rizatriptan—Erythema—Docetaxel—melanoma	0.000548	0.00195	CcSEcCtD
Rizatriptan—Hypersensitivity—Dactinomycin—melanoma	0.000547	0.00195	CcSEcCtD
Rizatriptan—Dysgeusia—Docetaxel—melanoma	0.000536	0.00191	CcSEcCtD
Rizatriptan—Urticaria—Temozolomide—melanoma	0.000534	0.0019	CcSEcCtD
Rizatriptan—Asthenia—Dactinomycin—melanoma	0.000533	0.0019	CcSEcCtD
Rizatriptan—Abdominal pain—Temozolomide—melanoma	0.000531	0.0019	CcSEcCtD
Rizatriptan—Body temperature increased—Temozolomide—melanoma	0.000531	0.0019	CcSEcCtD
Rizatriptan—Muscle spasms—Docetaxel—melanoma	0.000526	0.00188	CcSEcCtD
Rizatriptan—Hypersensitivity—Carmustine—melanoma	0.000512	0.00183	CcSEcCtD
Rizatriptan—Diarrhoea—Dactinomycin—melanoma	0.000508	0.00181	CcSEcCtD
Rizatriptan—Vomiting—Bleomycin—melanoma	0.000507	0.00181	CcSEcCtD
Rizatriptan—Rash—Bleomycin—melanoma	0.000502	0.00179	CcSEcCtD
Rizatriptan—Dermatitis—Bleomycin—melanoma	0.000502	0.00179	CcSEcCtD
Rizatriptan—Asthenia—Carmustine—melanoma	0.000499	0.00178	CcSEcCtD
Rizatriptan—Hypersensitivity—Temozolomide—melanoma	0.000495	0.00177	CcSEcCtD
Rizatriptan—Syncope—Docetaxel—melanoma	0.000491	0.00175	CcSEcCtD
Rizatriptan—Palpitations—Docetaxel—melanoma	0.000484	0.00173	CcSEcCtD
Rizatriptan—Asthenia—Temozolomide—melanoma	0.000482	0.00172	CcSEcCtD
Rizatriptan—Loss of consciousness—Docetaxel—melanoma	0.000481	0.00172	CcSEcCtD
Rizatriptan—Cough—Docetaxel—melanoma	0.000478	0.00171	CcSEcCtD
Rizatriptan—Diarrhoea—Carmustine—melanoma	0.000476	0.0017	CcSEcCtD
Rizatriptan—Pruritus—Temozolomide—melanoma	0.000475	0.0017	CcSEcCtD
Rizatriptan—Convulsion—Docetaxel—melanoma	0.000474	0.00169	CcSEcCtD
Rizatriptan—Nausea—Bleomycin—melanoma	0.000473	0.00169	CcSEcCtD
Rizatriptan—Hypertension—Docetaxel—melanoma	0.000473	0.00169	CcSEcCtD
Rizatriptan—Vomiting—Dactinomycin—melanoma	0.000472	0.00169	CcSEcCtD
Rizatriptan—Rash—Dactinomycin—melanoma	0.000469	0.00167	CcSEcCtD
Rizatriptan—Chest pain—Docetaxel—melanoma	0.000466	0.00166	CcSEcCtD
Rizatriptan—Myalgia—Docetaxel—melanoma	0.000466	0.00166	CcSEcCtD
Rizatriptan—Arthralgia—Docetaxel—melanoma	0.000466	0.00166	CcSEcCtD
Rizatriptan—Dizziness—Carmustine—melanoma	0.00046	0.00164	CcSEcCtD
Rizatriptan—Diarrhoea—Temozolomide—melanoma	0.00046	0.00164	CcSEcCtD
Rizatriptan—Dry mouth—Docetaxel—melanoma	0.000456	0.00163	CcSEcCtD
Rizatriptan—Confusional state—Docetaxel—melanoma	0.000451	0.00161	CcSEcCtD
Rizatriptan—Anaphylactic shock—Docetaxel—melanoma	0.000447	0.00159	CcSEcCtD
Rizatriptan—Oedema—Docetaxel—melanoma	0.000447	0.00159	CcSEcCtD
Rizatriptan—Dizziness—Temozolomide—melanoma	0.000444	0.00159	CcSEcCtD
Rizatriptan—Vomiting—Carmustine—melanoma	0.000442	0.00158	CcSEcCtD
Rizatriptan—Nausea—Dactinomycin—melanoma	0.000441	0.00157	CcSEcCtD
Rizatriptan—Shock—Docetaxel—melanoma	0.00044	0.00157	CcSEcCtD
Rizatriptan—Rash—Carmustine—melanoma	0.000438	0.00156	CcSEcCtD
Rizatriptan—Nervous system disorder—Docetaxel—melanoma	0.000438	0.00156	CcSEcCtD
Rizatriptan—Dermatitis—Carmustine—melanoma	0.000438	0.00156	CcSEcCtD
Rizatriptan—Tachycardia—Docetaxel—melanoma	0.000436	0.00156	CcSEcCtD
Rizatriptan—Headache—Carmustine—melanoma	0.000436	0.00155	CcSEcCtD
Rizatriptan—Vomiting—Temozolomide—melanoma	0.000427	0.00152	CcSEcCtD
Rizatriptan—Anorexia—Docetaxel—melanoma	0.000426	0.00152	CcSEcCtD
Rizatriptan—Rash—Temozolomide—melanoma	0.000424	0.00151	CcSEcCtD
Rizatriptan—Dermatitis—Temozolomide—melanoma	0.000423	0.00151	CcSEcCtD
Rizatriptan—Headache—Temozolomide—melanoma	0.000421	0.0015	CcSEcCtD
Rizatriptan—Nausea—Carmustine—melanoma	0.000413	0.00147	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000407	0.00145	CcSEcCtD
Rizatriptan—Insomnia—Docetaxel—melanoma	0.000404	0.00144	CcSEcCtD
Rizatriptan—Paraesthesia—Docetaxel—melanoma	0.000401	0.00143	CcSEcCtD
Rizatriptan—Nausea—Temozolomide—melanoma	0.000399	0.00142	CcSEcCtD
Rizatriptan—Dyspnoea—Docetaxel—melanoma	0.000398	0.00142	CcSEcCtD
Rizatriptan—Somnolence—Docetaxel—melanoma	0.000397	0.00142	CcSEcCtD
Rizatriptan—Dyspepsia—Docetaxel—melanoma	0.000393	0.0014	CcSEcCtD
Rizatriptan—Decreased appetite—Docetaxel—melanoma	0.000389	0.00139	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Docetaxel—melanoma	0.000386	0.00138	CcSEcCtD
Rizatriptan—Fatigue—Docetaxel—melanoma	0.000385	0.00137	CcSEcCtD
Rizatriptan—Pain—Docetaxel—melanoma	0.000382	0.00136	CcSEcCtD
Rizatriptan—Constipation—Docetaxel—melanoma	0.000382	0.00136	CcSEcCtD
Rizatriptan—Feeling abnormal—Docetaxel—melanoma	0.000368	0.00131	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Docetaxel—melanoma	0.000365	0.0013	CcSEcCtD
Rizatriptan—Abdominal pain—Docetaxel—melanoma	0.000353	0.00126	CcSEcCtD
Rizatriptan—Body temperature increased—Docetaxel—melanoma	0.000353	0.00126	CcSEcCtD
Rizatriptan—Hypersensitivity—Docetaxel—melanoma	0.000329	0.00117	CcSEcCtD
Rizatriptan—Asthenia—Docetaxel—melanoma	0.000321	0.00114	CcSEcCtD
Rizatriptan—Pruritus—Docetaxel—melanoma	0.000316	0.00113	CcSEcCtD
Rizatriptan—Diarrhoea—Docetaxel—melanoma	0.000306	0.00109	CcSEcCtD
Rizatriptan—Dizziness—Docetaxel—melanoma	0.000296	0.00105	CcSEcCtD
Rizatriptan—Vomiting—Docetaxel—melanoma	0.000284	0.00101	CcSEcCtD
Rizatriptan—Rash—Docetaxel—melanoma	0.000282	0.00101	CcSEcCtD
Rizatriptan—Dermatitis—Docetaxel—melanoma	0.000282	0.001	CcSEcCtD
Rizatriptan—Headache—Docetaxel—melanoma	0.00028	0.000999	CcSEcCtD
Rizatriptan—Nausea—Docetaxel—melanoma	0.000265	0.000947	CcSEcCtD
Rizatriptan—CYP1A2—Metabolism—GPAM—melanoma	3.32e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CB—melanoma	3.31e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL2—melanoma	3.29e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TERT—melanoma	3.27e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAC1—melanoma	3.27e-05	0.000189	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL2—melanoma	3.22e-05	0.000187	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TERT—melanoma	3.21e-05	0.000186	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAC1—melanoma	3.2e-05	0.000185	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—melanoma	3.18e-05	0.000184	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HRAS—melanoma	3.16e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—melanoma	3.13e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1B—melanoma	3.1e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SOCS1—melanoma	3.09e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAP2K1—melanoma	3.08e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—S100B—melanoma	3.08e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—melanoma	3.07e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—melanoma	3.07e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CD—melanoma	3.06e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—melanoma	3.04e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL2—melanoma	3.04e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—melanoma	3.02e-05	0.000175	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—melanoma	2.99e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCND1—melanoma	2.96e-05	0.000172	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB4—melanoma	2.95e-05	0.000171	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CB—melanoma	2.94e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—melanoma	2.93e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CTNNB1—melanoma	2.93e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN2B—melanoma	2.92e-05	0.000169	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CG—melanoma	2.89e-05	0.000168	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FN1—melanoma	2.88e-05	0.000167	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—melanoma	2.87e-05	0.000167	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1A—melanoma	2.86e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTEN—melanoma	2.86e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NFKB1—melanoma	2.84e-05	0.000165	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CD86—melanoma	2.83e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—melanoma	2.82e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FN1—melanoma	2.82e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH1—melanoma	2.82e-05	0.000164	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G6—melanoma	2.82e-05	0.000163	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—melanoma	2.8e-05	0.000163	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—melanoma	2.79e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—melanoma	2.79e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CD80—melanoma	2.76e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH1—melanoma	2.76e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APC—melanoma	2.76e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—melanoma	2.76e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIT—melanoma	2.76e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—NRAS—melanoma	2.76e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CSF2—melanoma	2.74e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF1—melanoma	2.74e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGF—melanoma	2.73e-05	0.000158	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CD80—melanoma	2.71e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—melanoma	2.7e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIT—melanoma	2.7e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APC—melanoma	2.7e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—NRAS—melanoma	2.7e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—melanoma	2.7e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—E2F1—melanoma	2.68e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGF—melanoma	2.67e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CB—melanoma	2.67e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFRA—melanoma	2.65e-05	0.000154	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK3—melanoma	2.64e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ITGB3—melanoma	2.63e-05	0.000152	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCA—melanoma	2.63e-05	0.000152	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—melanoma	2.59e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK3—melanoma	2.59e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—melanoma	2.58e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SPP1—melanoma	2.58e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAP2K2—melanoma	2.57e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—melanoma	2.56e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—melanoma	2.55e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NRAS—melanoma	2.55e-05	0.000148	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CD—melanoma	2.54e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—melanoma	2.54e-05	0.000147	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—VCAN—melanoma	2.53e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—melanoma	2.53e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK1—melanoma	2.51e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—melanoma	2.51e-05	0.000146	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—melanoma	2.51e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—melanoma	2.47e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK1—melanoma	2.46e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—melanoma	2.46e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—melanoma	2.45e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—melanoma	2.44e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAP2K1—melanoma	2.44e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK3—melanoma	2.44e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAC1—melanoma	2.44e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CD—melanoma	2.43e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—melanoma	2.4e-05	0.000139	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.4e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAP2K1—melanoma	2.39e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CD—melanoma	2.37e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—melanoma	2.37e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—melanoma	2.37e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—melanoma	2.35e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—melanoma	2.34e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—melanoma	2.32e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK1—melanoma	2.32e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF2—melanoma	2.32e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—melanoma	2.32e-05	0.000135	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.31e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF2—melanoma	2.27e-05	0.000132	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—melanoma	2.23e-05	0.00013	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CB—melanoma	2.22e-05	0.000129	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—melanoma	2.2e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—melanoma	2.19e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—melanoma	2.18e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MDM2—melanoma	2.17e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FN1—melanoma	2.15e-05	0.000125	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB2—melanoma	2.14e-05	0.000124	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP17A1—melanoma	2.14e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—melanoma	2.14e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MDM2—melanoma	2.13e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CB—melanoma	2.11e-05	0.000123	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.11e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—melanoma	2.1e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB2—melanoma	2.1e-05	0.000122	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.08e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CB—melanoma	2.07e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CD80—melanoma	2.06e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—melanoma	2.06e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APC—melanoma	2.06e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIT—melanoma	2.06e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—NRAS—melanoma	2.06e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGF—melanoma	2.03e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—melanoma	2.03e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HRAS—melanoma	2.02e-05	0.000117	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNA11—melanoma	2.02e-05	0.000117	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—melanoma	2.01e-05	0.000117	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—melanoma	1.99e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1B—melanoma	1.98e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HRAS—melanoma	1.98e-05	0.000115	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—FASN—melanoma	1.97e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK3—melanoma	1.97e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—melanoma	1.96e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—melanoma	1.95e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—melanoma	1.94e-05	0.000113	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC5A5—melanoma	1.94e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1B—melanoma	1.94e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—melanoma	1.94e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—melanoma	1.93e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—melanoma	1.93e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—melanoma	1.92e-05	0.000111	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—melanoma	1.92e-05	0.000111	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—melanoma	1.9e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—melanoma	1.9e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—melanoma	1.89e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—melanoma	1.89e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—melanoma	1.88e-05	0.000109	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNAQ—melanoma	1.88e-05	0.000109	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD44—melanoma	1.88e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK1—melanoma	1.87e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—melanoma	1.87e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNB1—melanoma	1.87e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HRAS—melanoma	1.86e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—melanoma	1.85e-05	0.000107	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—melanoma	1.84e-05	0.000107	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.84e-05	0.000107	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNB1—melanoma	1.83e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1A—melanoma	1.83e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—melanoma	1.83e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAP2K1—melanoma	1.82e-05	0.000106	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.82e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKB1—melanoma	1.82e-05	0.000105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CD—melanoma	1.81e-05	0.000105	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—melanoma	1.8e-05	0.000104	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1B1—melanoma	1.8e-05	0.000104	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1A—melanoma	1.79e-05	0.000104	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	1.79e-05	0.000104	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—melanoma	1.79e-05	0.000104	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—melanoma	1.78e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—melanoma	1.78e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKB1—melanoma	1.78e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—melanoma	1.77e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—melanoma	1.74e-05	0.000101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF2—melanoma	1.73e-05	0.0001	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—melanoma	1.65e-05	9.57e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—melanoma	1.65e-05	9.54e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—melanoma	1.63e-05	9.47e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NRAS—melanoma	1.63e-05	9.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—melanoma	1.63e-05	9.43e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MDM2—melanoma	1.62e-05	9.4e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—melanoma	1.62e-05	9.37e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—melanoma	1.6e-05	9.27e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB2—melanoma	1.6e-05	9.26e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NRAS—melanoma	1.6e-05	9.25e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.59e-05	9.2e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CB—melanoma	1.58e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK3—melanoma	1.56e-05	9.05e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK3—melanoma	1.53e-05	8.86e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—melanoma	1.52e-05	8.8e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—melanoma	1.52e-05	8.79e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HRAS—melanoma	1.51e-05	8.73e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—melanoma	1.49e-05	8.62e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK1—melanoma	1.48e-05	8.61e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—melanoma	1.48e-05	8.61e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—melanoma	1.48e-05	8.59e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1B—melanoma	1.48e-05	8.58e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—melanoma	1.46e-05	8.49e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK1—melanoma	1.45e-05	8.43e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—melanoma	1.45e-05	8.43e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—melanoma	1.45e-05	8.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—melanoma	1.45e-05	8.4e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—melanoma	1.44e-05	8.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—melanoma	1.41e-05	8.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—melanoma	1.4e-05	8.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNB1—melanoma	1.4e-05	8.11e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—melanoma	1.37e-05	7.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—melanoma	1.37e-05	7.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1A—melanoma	1.37e-05	7.92e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PRKCA—melanoma	1.36e-05	7.9e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—melanoma	1.36e-05	7.9e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKB1—melanoma	1.36e-05	7.86e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—melanoma	1.35e-05	7.84e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ERCC2—melanoma	1.35e-05	7.84e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—melanoma	1.33e-05	7.71e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—melanoma	1.29e-05	7.47e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—melanoma	1.26e-05	7.32e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—melanoma	1.25e-05	7.23e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—melanoma	1.23e-05	7.14e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—melanoma	1.22e-05	7.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—melanoma	1.22e-05	7.07e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NRAS—melanoma	1.22e-05	7.05e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HRAS—melanoma	1.19e-05	6.91e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HRAS—melanoma	1.17e-05	6.77e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK3—melanoma	1.16e-05	6.75e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—melanoma	1.14e-05	6.62e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—melanoma	1.13e-05	6.57e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.12e-05	6.49e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—melanoma	1.12e-05	6.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK1—melanoma	1.11e-05	6.42e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—melanoma	1.11e-05	6.42e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—melanoma	1.1e-05	6.41e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—melanoma	1.07e-05	6.19e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—melanoma	1.05e-05	6.1e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—melanoma	1.05e-05	6.07e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—melanoma	1.03e-05	5.98e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—melanoma	1.03e-05	5.98e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—melanoma	9.61e-06	5.57e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CD—melanoma	9.39e-06	5.44e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—melanoma	9.3e-06	5.39e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—melanoma	9.27e-06	5.37e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRAS—melanoma	8.89e-06	5.16e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—melanoma	8.51e-06	4.94e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CB—melanoma	8.18e-06	4.74e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—melanoma	8.11e-06	4.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—melanoma	7.85e-06	4.55e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—melanoma	7.07e-06	4.1e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—melanoma	4.99e-06	2.89e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—melanoma	4.07e-06	2.36e-05	CbGpPWpGaD
